Efficacy and Safety of Yiqi Wenyang Sanhan Formula Combined With Acupoint Application in Patients With Combined Allergic Rhinitis and Asthma Syndrome During Remission and Yang-Deficiency Syndrome
Beijing Daxing District Hospital of Integrated Chinese and Western Medicine
Age
16–79
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Fulfilled the western medicine diagnostic criteria for CARAS.
2. Had clearly defined seasonal attack characteristics and were diagnosed with CARAS of the yang-deficiency syndrome type during the remission stage.
3. Were aged 16-79 years.
4. Were informed of the study details and provided written informed consent.
5. Had a general physical condition and mental status sufficient to ensure the objective and accurate reporting of symptom characteristics and treatment responses.
You may not be if
1. A diagnosis of vasomotor rhinitis or non-allergic rhinitis with eosinophilia syndrome.
2. Known or suspected allergy to any component of the study medication, or any contraindication to the study medication or glucocorticoid therapy.
3. Current participation in another drug trial, or concomitant use of other oral traditional Chinese medicines or external medicinal patches.
4. The presence of severe primary diseases affecting major organs or systems, including the cardiovascular, hepatic, renal, or hematopoietic systems, or the presence of a psychiatric disorder.
5. Pregnancy or lactation.
6. Inability to clearly provide syndrome-related information.
Clareo Health | Efficacy and Safety of Yiqi Wenyang Sanhan Formula Combined With Acupoint Application in Patients With Combined Allergic Rhinitis and Asthma Syndrome During Remission and Yang-Deficiency Syndrome
